Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 14, 2022

Study Completion Date

August 14, 2022

Conditions
Cocaine DependenceHealthy
Interventions
DRUG

N-acetyl cysteine

Upon completion of baseline (abstinence) 1H-MRS scanning, CU and HC subjects will participate in two additional 1H-MRS scans, including after 2 weeks of placebo and 2 weeks of NAC administration (3600 mg/day) given in double-blind, randomized, counterbalanced order.

DIAGNOSTIC_TEST

[18F]FDG PET scan

All subjects will undergo \[18F\]FDG PET to establish previously demonstrated reductions in glucose utilization in PFC and assess VS/nucleus accumbent metabolism at baseline.

DIAGNOSTIC_TEST

1H MRS

All subjects will undergo three magnetic resonance spectroscopy (1H-MRS) scans at 7T, including before and after two-weeks of placebo and NAC administration.

DIAGNOSTIC_TEST

[11C]APP311 PET scan

All subjects will undergo \[11C\]APP311 PET imaging to investigate whether there are differences in synaptic integrity / neuronal plasticity in the brains of individuals abstinent from cocaine compared to healthy controls at baseline.

Trial Locations (1)

06519

Connecticut Mental Health Center, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT02124941 - Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS | Biotech Hunter | Biotech Hunter